Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Student one of ten Google Young Minds
2012-04-23

 

Sibusiso Tshabalala is making strides as an international young leader.
23 April 2012

Third-year B.Com Law student, Sibusiso Tshabalala from our university, is one of ten of Google’s Young Minds for 2012. He made it to the top thirty from a pool of 1 700 applicants at the beginning of April 2012.

“The standard of other competitors and the panel of judges were extremely high. I was excited to receive the news that I had made it,” he says.

Annually, Google searches for ten students internationally who demonstrate strong leadership capabilities. This once-in-a-lifetime opportunity is given to students who also have an entrepreneurial drive and a commitment to social activism. Sibusiso was selected for his involvement in renovating libraries and training budding public speakers. His projects also involve encouraging literacy and critical thinking in poor areas in the Free State by establishing reading clubs.

Sibusiso will be attending the Google Zeitgeist in London from 20 to 22 May 2012.

At the conference, he will have the opportunity to meet some of the world’s greatest minds. Over 400 influential business leaders and visionaries from around the world will be hosted. Speakers include Prof. Stephen Hawking, former Lucasian Professor of Mathematics: University of Cambridge; Sir Richard Branson, Virgin Group; Eric Schmidt, Chairman: Google; Larry Page, CEO: Google; Angela Ahrendts, CEO: Burberry, and international musician will.i.am.

The ten winners will also take part in a series of ‘master classes’ with the aim of mentoring them to help further their future projects.

His achievements include the 2010 winner of the National SAGE Competition (Students for the Advancement of Global Entrepreneurship). He represented South Africa in Brazil that same year and was also National Winner of the Best Speaker Award at the 2011 South African National Universities Debating Championships. He was ranked as one of the top ten debaters in Africa at the Pan African Universities Debating Championships held in Bulawayo, Zimbabwe in 2011. Sibusiso recently chaired the committee that organised the first university based CANSA Relay for Life Event in South Africa. This took place at the UFS in February 2012.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept